[Biochemical modulation by leucovorin of the antineoplastic effect of fluorofur in disseminated colorectal cancer].
Manziuk
L V
LV
Perevodchikova
N I
NI
Gorbunova
V A
VA
Luk'ianchenko
A B
AB
Abramova
N A
NA
D000328:Adult; D000368:Aged; D000964:Antimetabolites, Antineoplastic / Q000008:administration & dosage* / Q000009:adverse effects; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology; D018450:Disease Progression; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000008:administration & dosage* / Q000009:adverse effects; D002955:Leucovorin / Q000008:administration & dosage* / Q000009:adverse effects; D008297:Male; D008875:Middle Aged; D005641:Tegafur / Q000008:administration & dosage* / Q000009:adverse effects; D016896:Treatment Outcome
D000964:Antimetabolites, Antineoplastic; D007155:Immunologic Factors; D005641:Tegafur; D002955:Leucovorin